What are the obligations of pharmaceutical companies in a global health emergency?

Ezekiel J. Emanuel; Allen Buchanan; Shuk Ying Chan; Cecile Fabre; Daniel Halliday; Joseph Heath; Lisa Herzog; R. J. Leland; Matthew S. McCoy; Ole F. Norheim; Carla Saenz; G. Owen Schaefer; Kok-Chor Tan; Christopher Heath Wellman; Jonathan Wolff; Govind Persad

doi:10.1016/S0140-6736(21)01378-7

What are the obligations of pharmaceutical companies in a global health emergency?

Ezekiel J. Emanuel^*, Allen Buchanan, Shuk Ying Chan, Cecile Fabre, Daniel Halliday, Joseph Heath, Lisa Herzog, R. J. Leland, Matthew S. McCoy, Ole F. Norheim, Carla Saenz, G. Owen Schaefer, Kok-Chor Tan, Christopher Heath Wellman, Jonathan Wolff, Govind Persad

^*Bijbehorende auteur voor dit werk

Ethiek, Sociale en Politieke Filosofie

Onderzoeksoutput › Academic › peer review

6 Downloads (Pure)

Originele taal-2	English
Pagina's (van-tot)	1015-1020
Aantal pagina's	6
Tijdschrift	LANCET
Volume	398
Nummer van het tijdschrift	10304
DOI's	https://doi.org/10.1016/S0140-6736(21)01378-7
Status	Published - 11-sep-2021

Toegang tot document

10.1016/S0140-6736(21)01378-7

What are the obligations of pharmaceutical companies in a global health emergency?Final publisher's version, 142 KBLicentie: Taverne

Citeer dit

Emanuel, E. J., Buchanan, A., Chan, S. Y., Fabre, C., Halliday, D., Heath, J., Herzog, L., Leland, R. J., McCoy, M. S., Norheim, O. F., Saenz, C., Schaefer, G. O., Tan, K-C., Wellman, C. H., Wolff, J., & Persad, G. (2021). What are the obligations of pharmaceutical companies in a global health emergency? LANCET, 398(10304), 1015-1020. https://doi.org/10.1016/S0140-6736(21)01378-7

Emanuel, Ezekiel J. ; Buchanan, Allen ; Chan, Shuk Ying ; Fabre, Cecile ; Halliday, Daniel ; Heath, Joseph ; Herzog, Lisa ; Leland, R. J. ; McCoy, Matthew S. ; Norheim, Ole F. ; Saenz, Carla ; Schaefer, G. Owen ; Tan, Kok-Chor ; Wellman, Christopher Heath ; Wolff, Jonathan ; Persad, Govind. / What are the obligations of pharmaceutical companies in a global health emergency?. In: LANCET. 2021 ; Vol. 398, Nr. 10304. blz. 1015-1020.

@article{8be6c94a6ecf40f198e9fa67b5b21e54,

title = "What are the obligations of pharmaceutical companies in a global health emergency?",

author = "Emanuel, {Ezekiel J.} and Allen Buchanan and Chan, {Shuk Ying} and Cecile Fabre and Daniel Halliday and Joseph Heath and Lisa Herzog and Leland, {R. J.} and McCoy, {Matthew S.} and Norheim, {Ole F.} and Carla Saenz and Schaefer, {G. Owen} and Kok-Chor Tan and Wellman, {Christopher Heath} and Jonathan Wolff and Govind Persad",

year = "2021",

month = sep,

day = "11",

doi = "10.1016/S0140-6736(21)01378-7",

language = "English",

volume = "398",

pages = "1015--1020",

journal = "The Lancet",

issn = "0140-6736",

publisher = "ELSEVIER SCIENCE INC",

number = "10304",

}

What are the obligations of pharmaceutical companies in a global health emergency? / Emanuel, Ezekiel J.; Buchanan, Allen; Chan, Shuk Ying; Fabre, Cecile; Halliday, Daniel; Heath, Joseph; Herzog, Lisa; Leland, R. J.; McCoy, Matthew S.; Norheim, Ole F.; Saenz, Carla; Schaefer, G. Owen; Tan, Kok-Chor; Wellman, Christopher Heath; Wolff, Jonathan; Persad, Govind.